A Liquid-Based Cytology (LBC) Pap smear—often called an LBC Pap or liquid Pap—is a cervical cancer screening test that looks for abnormal changes in cells from the cervix (the lower part of the uterus that opens into the vagina). It is a modern form of cervical cytology that uses a liquid preservative to better protect and prepare the cells for examination under a microscope.

During the test, a clinician gently collects cells from the cervix using a small brush or spatula. Instead of smearing the sample directly on a glass slide (as in a conventional Pap smear), the brush head or collected material is placed into a vial of liquid. In the laboratory, the cells are filtered and spread into a thin, even layer, which helps reduce obscuring blood or mucus and improves the clarity of the sample. This can make it easier to detect early cell changes that may lead to cancer.

What it measures: The LBC Pap smear evaluates the appearance of cervical cells to identify inflammation, infection-related changes, precancerous abnormalities, or cancer. Results are typically reported using standardized categories (such as “negative for intraepithelial lesion or malignancy” or various types of “abnormal/atypical” findings).

What results mean in plain language:

Normal/negative result: No concerning cell changes were seen. This usually means you can continue routine cervical cancer screening at the recommended interval for your age and risk.

Abnormal result: Some cervical cells look different than expected. Many abnormal results are caused by temporary HPV infection or benign changes and do not mean you have cancer. Depending on the type of abnormality, your clinician may recommend repeating the test, doing HPV testing (often done on the same liquid sample), or performing further evaluation such as colposcopy (a closer look at the cervix) and possible biopsy.

Unsatisfactory/inadequate sample: Not enough cells were collected or the sample was obscured. You may be asked to repeat the test.

An LBC Pap smear is most commonly done as part of routine cervical cancer screen and prevention. It is designed to find precancerous changes early—often before any symptoms appear—so they can be monitored or treated to reduce the risk of cervical cancer.

Your doctor may recommend an lbc pap or liquid pap:

For routine screening: Many people have no symptoms, so screening is based on age and risk. Screening schedules vary by country and guideline, but Pap and/or HPV-based screening is typically recommended for adults with a cervix within certain age ranges. Your clinician will advise the right interval for you.

If you have symptoms that need evaluation (not just screening): While a Pap smear is not a definitive test for the cause of symptoms, it may be part of a broader workup if you have:

Abnormal vaginal bleeding (bleeding after sex, between periods, or after menopause)

Unusual vaginal discharge or persistent pelvic discomfort

Pain or bleeding with intercourse

If you have higher risk factors for cervical cell changes: Your clinician may recommend closer follow-up or more frequent testing if you have:

A history of abnormal Pap results or positive high-risk HPV

A weakened immune system (e.g., due to HIV or certain immune-suppressing medications)

Smoking (associated with higher risk of cervical precancer)

Exposure to certain factors in the past (your clinician will review your individual history)

Because the sample is preserved in liquid, LBC often allows labs to perform reflex HPV testing (HPV testing done automatically if certain abnormalities are found), which can improve risk assessment and next-step decisions.

• Precancerous cervical changes (cervical intraepithelial neoplasia, CIN)
• Cervical cancer (screening detection of possible malignancy)
• Human papillomavirus (HPV) infection and HPV-related cervical changes
• Atypical squamous or glandular cell changes (ASC-US, ASC-H, LSIL, HSIL, AGC)
• Cervicitis (inflammation of the cervix)
• Vaginal infections that can affect cytology appearance (e.g., bacterial vaginosis, yeast)

• Early detection and prevention of cervical cancer through routine cervical cytology screening
• Monitoring cervical health after a prior abnormal Pap smear or treatment for precancer (e.g., after colposcopy/biopsy or procedures like LEEP)
• Assessing risk and guiding next steps when combined with HPV testing (co-testing or reflex testing)
• Supporting reproductive and gynecologic preventive care planning (regular wellness visits and age-appropriate screening)